NO960123L - Fluorescerende lateks inneholdende to fluorkrom, fremgangsmåte for fremstilling av den og anvendelse av denne - Google Patents

Fluorescerende lateks inneholdende to fluorkrom, fremgangsmåte for fremstilling av den og anvendelse av denne

Info

Publication number
NO960123L
NO960123L NO960123A NO960123A NO960123L NO 960123 L NO960123 L NO 960123L NO 960123 A NO960123 A NO 960123A NO 960123 A NO960123 A NO 960123A NO 960123 L NO960123 L NO 960123L
Authority
NO
Norway
Prior art keywords
fluorochromes
preparation
latex containing
fluorescent latex
fluorescent
Prior art date
Application number
NO960123A
Other languages
English (en)
Other versions
NO960123D0 (no
NO308253B1 (no
Inventor
Sophie Vaslin
Joel Richard
Dominique Teychenne
Frederic Ricchiero
Dan Lerner
Original Assignee
Prolabo Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prolabo Sa filed Critical Prolabo Sa
Publication of NO960123D0 publication Critical patent/NO960123D0/no
Publication of NO960123L publication Critical patent/NO960123L/no
Publication of NO308253B1 publication Critical patent/NO308253B1/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/0008—Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
    • C08K5/0041—Optical brightening agents, organic pigments
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K9/00—Use of pretreated ingredients
    • C08K9/10—Encapsulated ingredients
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO960123A 1993-07-12 1996-01-11 Fluorescerende lateks inneholdende to fluorkrom, fremgangsmÕte for fremstilling av den og anvendelse av denne NO308253B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9308573A FR2707658B1 (fr) 1993-07-12 1993-07-12 Latex fluorescent comportant au moins deux fluorochromes, procédé d'obtention et application dudit latex comme marqueur, notamment en biologie.
PCT/FR1994/000867 WO1995002635A1 (fr) 1993-07-12 1994-07-11 Latex fluorescent comportant au moins deux fluorochromes, procede d'obtention et application

Publications (3)

Publication Number Publication Date
NO960123D0 NO960123D0 (no) 1996-01-11
NO960123L true NO960123L (no) 1996-03-12
NO308253B1 NO308253B1 (no) 2000-08-21

Family

ID=9449186

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960123A NO308253B1 (no) 1993-07-12 1996-01-11 Fluorescerende lateks inneholdende to fluorkrom, fremgangsmÕte for fremstilling av den og anvendelse av denne

Country Status (10)

Country Link
US (1) US5716855A (no)
EP (1) EP0712426B1 (no)
JP (1) JPH09504041A (no)
CA (1) CA2167072C (no)
DE (1) DE69403663T2 (no)
DK (1) DK0712426T3 (no)
ES (1) ES2104405T3 (no)
FR (1) FR2707658B1 (no)
NO (1) NO308253B1 (no)
WO (1) WO1995002635A1 (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251581B1 (en) 1991-05-22 2001-06-26 Dade Behring Marburg Gmbh Assay method utilizing induced luminescence
US5578498A (en) * 1991-05-22 1996-11-26 Behringwerke Ag Metal chelate containing compositions for use in chemiluminescent assays
US6238931B1 (en) * 1993-09-24 2001-05-29 Biosite Diagnostics, Inc. Fluorescence energy transfer in particles
GB9602265D0 (en) * 1996-02-05 1996-04-03 Amersham Int Plc Benzophenoxazine dyes
JP3338616B2 (ja) * 1996-09-05 2002-10-28 富士通株式会社 蛍光体層の形成方法及び蛍光体ペースト
US6632526B1 (en) * 1997-10-14 2003-10-14 Luminex Corporation Precision fluorescently dyed particles and methods of making and using same
JP2002504689A (ja) 1998-02-18 2002-02-12 デイド・ベーリング・インコーポレイテッド 複数の検体の検出において使用するための化学ルミネセンス組成物
IL141759A0 (en) * 1998-09-03 2002-03-10 Trellis Bioinformatics Inc Multihued labels
US6642062B2 (en) * 1998-09-03 2003-11-04 Trellis Bioinformatics, Inc. Multihued labels
US6703248B1 (en) * 1999-12-15 2004-03-09 Dade Behring Marburg Gmbh Particles for diagnostic and therapeutic use
US20050164261A1 (en) * 2001-10-09 2005-07-28 Chandler Don J. Multiplexed analysis of clinical specimens apparatus and methods
US8148171B2 (en) 2001-10-09 2012-04-03 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods
WO2005003182A2 (en) * 2003-07-02 2005-01-13 Perkinelmer Las, Inc. Scintillator composition for a radioassay, and method for its use
US7407816B2 (en) * 2004-05-07 2008-08-05 Gentius, Inc Isoelectric particles and uses thereof
WO2006027738A1 (en) * 2004-09-10 2006-03-16 Philips Intellectual Property & Standards Gmbh Compounds and methods for combined optical-ultrasound imaging
WO2006115870A2 (en) * 2005-04-20 2006-11-02 Becton Dickinson And Company Multiplex microparticle system
US7939613B2 (en) * 2005-04-22 2011-05-10 The Hong Kong University Of Science And Technology Fluorescent water-soluble conjugated polyene compounds that exhibit aggregation induced emission and methods of making and using same
NO20053373D0 (no) 2005-07-11 2005-07-11 Rikshospitalet Radiumhospitale Multicolored Particles.
JP2012517487A (ja) 2009-02-09 2012-08-02 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 電気泳動ディスプレイのための粒子
WO2010089058A1 (en) 2009-02-09 2010-08-12 Merck Patent Gmbh, Coloured particles for electrophoretic displays
CN102307912B (zh) 2009-02-09 2015-05-27 默克专利有限公司 用于电泳显示器的颗粒
JP2012517486A (ja) 2009-02-09 2012-08-02 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 電気泳動ディスプレイのための着色粒子
GB2475226A (en) * 2009-11-03 2011-05-18 Genetic Analysis As Universal Prokaryote 16S ribosome PCR primer pair
GB201021397D0 (en) 2010-12-16 2011-01-26 Genetic Analysis As Diagnosis of Crohn's disease
GB201021399D0 (en) 2010-12-16 2011-01-26 Genetic Analysis As Oligonucleotide probe set and methods of microbiota profiling
GB201102693D0 (en) 2011-02-16 2011-03-30 Genetic Analysis As Method for identifying neonates at risk for necrotizing enterocolitis
US9227181B2 (en) 2011-09-13 2016-01-05 Basf Corporation Catalyst to increase propylene yields from a fluid catalytic cracking unit
WO2014166583A1 (en) 2013-04-12 2014-10-16 Merck Patent Gmbh Particles for electrophoretic displays
EP3233944B1 (en) 2014-12-19 2019-09-04 Merck Patent GmbH Particles for electrophoretic displays
EP3508851A4 (en) * 2016-08-31 2020-07-29 Sekisui Chemical Co., Ltd. FLUORESCENT PARTICLES FOR A DIAGNOSIS AGENT AND IMMUNOLOGICAL ASSAY REAGENT USER
AU2018256453B2 (en) 2017-04-20 2024-02-08 The University Of Chicago Methods and compositions for treating cancer with ECM-affinity peptides linked to immunotherapeutic antibodies
US12436080B2 (en) 2020-02-24 2025-10-07 Corning Incorporated Calibration set including nanoparticles of nylon-6 and dyes
CN111363539A (zh) * 2020-04-30 2020-07-03 上海思滤科技有限公司 一种单分散多色发光微球及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3000483A1 (de) * 1979-01-09 1980-07-17 Fuji Photo Film Co Ltd Mikrokapseln fuer immunologische bestimmungen
US5073497A (en) * 1989-06-30 1991-12-17 Caribbean Microparticles Corporation Microbead reference standard and method of adjusting a flow cytometer to obtain reproducible results using the microbeads
EP0280556B1 (en) * 1987-02-27 1994-08-10 EASTMAN KODAK COMPANY (a New Jersey corporation) Water-insoluble particle and immunoreactive reagent, analytical elements and methods of use
US5607864A (en) * 1992-04-07 1997-03-04 Societe Prolabo Fluorescent latices having very low detection thresholds for fluorescent emission
US5264960A (en) * 1992-05-08 1993-11-23 At&T Bell Laboratories Optical wavelength shifter
US5369036A (en) * 1992-07-02 1994-11-29 Becton, Dickinson And Company Enhancement of signal in immunoassays using microparticles which contain different detectable substances
US5393527A (en) * 1993-01-04 1995-02-28 Becton, Dickinson And Company Stabilized microspheres and methods of preparation

Also Published As

Publication number Publication date
CA2167072A1 (fr) 1995-01-26
EP0712426B1 (fr) 1997-06-04
US5716855A (en) 1998-02-10
ES2104405T3 (es) 1997-10-01
DE69403663T2 (de) 1998-01-02
CA2167072C (fr) 2008-10-28
DE69403663D1 (de) 1997-07-10
FR2707658B1 (fr) 1995-11-24
EP0712426A1 (fr) 1996-05-22
NO960123D0 (no) 1996-01-11
DK0712426T3 (da) 1997-12-22
NO308253B1 (no) 2000-08-21
WO1995002635A1 (fr) 1995-01-26
JPH09504041A (ja) 1997-04-22
FR2707658A1 (fr) 1995-01-20

Similar Documents

Publication Publication Date Title
DK0712426T3 (da) Fluorescerende latex, som omfatter i det mindste to fluorokromer, fremgangsmåde til fremstilling deraf samt anvendelse deraf
NO981150D0 (no) Konsentrert, flytende vaskemiddelblanding og fremgangsmåte for fremstilling av denne
NO971680D0 (no) Antiskum-blanding og fremgangsmåte for fremstilling av denne
NO962179L (no) Fremgangsmåte for fremstilling av metallocen og anvendelse derav
DE69624248D1 (de) Verbesserter tft, dessen herstellungsverfahren und den tft enthaltende matrixanzeigen
AU4691789A (en) N-aryl-azetidinones, their preparation process and their use as elastase inhibitors
FI940810L (fi) Substituoidut bentseenisulfonyylivirtsa-aineet ja -tiovirtsa-aineet, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä
DK187687D0 (da) Fungicide forbindelser og fremgangsmaade til fremstilling deraf, midler indeholdende forbindelserne og disses anvendelse
FI946039L (fi) Substituoidut 1-okso-1,2-dihydro-isokinolinoyyli- ja 1,1-diokso-2H-1,2-bentsotiatsinoyyliguanidiinit, menetelmä niiden valmistamiseksi, niiden käyttö lääkeaineena tai diagnostisena aineena sekä niitä sisältävä lääkeaine
FI970094A7 (fi) Substituoidut bentsamidiinit, niiden valmistus ja käyttö lääkeaineena
DE68920335D1 (de) In vitro-verpackungsvorrichtung um dna-fragmente von 95-kb zu klonen.
NO179852C (no) Blanding som omfatter 1,2-benzisotiazolin-3-on og anvendelse derav
FR2599626B1 (fr) Antigene du flavivirus, procede pour sa production et vaccin le contenant
IT8748022A0 (it) Composti monoazoici contenenti gruppi triazinile, loro preparazione eloro impiego come coloranti
FI934611A7 (fi) Substituoituja (pyridinyyliamino)-bentsisoksatsoleja ja -bentso(b)tiofeenejä, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineina
FI903818A7 (fi) 1-(pyridinyyliamino)-2-pyrrolidoneja, menetelmä niiden valmistamiseksija niiden käyttö lääkkeinä
AU5847194A (en) Novel entomopoxvirus genes, proteins and methods of use thereof
DK0727416T3 (da) Substituerede benzensulfonylurinstoffer og -thiourinstoffer, og fremgangsmåde til deres fremstilling, deres anvendelse som
IT1219828B (it) Composti monoazoici reattivi,loro preparazione e loro impiego come coloranti
EP0755985A3 (de) Farbstoffmischungen, Verfahren zu ihrer Herstellung und ihre Verwendung
HUP9801068A2 (hu) 1,2,3,4-Tetrahidro-2-naftil-amin-származékok, ezek előállítása és alkalmazása, valamint ilyen származékokat tartalmazó gyógyászati készítmények
HRP960063B1 (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation and their use in the production of pharmaceutical preparations as well as pharmaceutical preparations containing them
IT1219792B (it) Composti monoozoici,loro preparazione e loro impiego come coloranti reattivi
FI944751L (fi) Heteroaryylipiperidiinejä, menetelmä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia
DK0728741T3 (da) Substituerede benzensulfonylurinstoffer og -thiourinstoffer, fremgangsmåde til fremstilling deraf, anvendelse deraf til fre

Legal Events

Date Code Title Description
MK1K Patent expired